Ultrastructural effects of topical beta-adrenergic antagonists and an alpha-adrenergic agonist on the rabbit cornea

Ophthalmologica

Volumn 213, Issue 3, 1999, Pages 183-188

  Polat, Sait ^a   Özdemir, Nusret ^a   Soylu, Merih ^a   Mete, Ufuk ^a   Ünlügenç, Zuhal ^a   Kaya, Mehmet ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Apraclonidine; Betaxolol; Cornea; Levobunolol; Timolol; Ultrastructure

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BALANCED SALT SOLUTION; BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; LEVOBUNOLOL; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CORNEA; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; DRUG EFFECT; ENDOPLASMIC RETICULUM; NONHUMAN; RABBIT; SCANNING ELECTRON MICROSCOPY; TOPICAL DRUG ADMINISTRATION; ULTRASTRUCTURE;

EID: 0032952483     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027416     Document Type: Article

References (18)

1. Fry LL: Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, lopidine, Diamox, Pilopine gel and Miostat. J Cataract Refract Surg 1992;18:14-19.
2. Coakes RL, Brubaker RF: The mechanism of timolol in lowering intraocular pressure in the normal eye. Arch Ophthalmol 1978;96:2045-2048.
3. Bartels SP, Roth O, Jumblatt MM, Neufeld AH: Pharmacological effects of topical timolol in the rabbit eye. Invest Ophthalmol Vis Sci 1980;19:1189-1197.
4. Cullom RD Jr, Schwartz LW: The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd: YAG laser posterior capsulotomy. Ophthalmic Surg 1993; 24:623-626.
5. Gharagozloo NZ, Brubaker RF: Effect of apraclonidine in long-term timolol users. Ophthalmology 1991;98:1543-1546.
6. Hill RA, Minckler DS, Lee M, Heuer DK, Baerveldt G, Martone JF: Apraclonidine prophylaxis for postcyloplegic intraocular pressure spikes. Ophthalmology 1991;98:1083-1086.
7. Toris CB, Tafoya ME, Camras CB, Yablonski ME: Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology 1995;102:456-461.
8. Robin AL, Ritch R, Shin DH, Smythe B, Mundorf T, Lehmann RP: Short-term efficacy of apraclonidine hydrochloride added to maximum tolerated medical therapy. Am J Ophthalmol 1995;120:423-432.
9. 4 solutions and fixation. J Appl Physics 1961;32:1637.
10. The Levobunolol Study Group: Levobunolol: A four-year study of efficacy and safety in glaucoma treatment. Ophthalmology 1989;96:642-645.
11. Liu GS, Trope GE, Basu PK: Ultrastructural effects of topical Betoptic, Betagan, and Timoptic on the rabbit corneal endothelium. J Ocul Pharmacol 1989;5:329-341.
12. Herreras JM, Pastor JC, Calonge M, Asensio VM: Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 1992;99:1082-1088.
13. Serdahl CL, Galustion J, Lewis RA: The effects of apraclonidine on conjunctival oxygen tension. Arch Ophthalmol 1989;107:1777-1779.
14. Nagasubramanian S, Hitchings RA, Demailly P, Chuniaud M, Pannarale MR, Pecori-Giraldi J, Stadmeister R, Parsons DG: Comparison of apraclonidine and timolol in chronic open angle glaucoma: A three-month study. Ophthalmology 1993;100:1318-1323.
15. Butler P, Mannschreck M, Lin S, Hwang I, Alvarado J: Clinical experience with the long term use of 1 % apraclonidine: Incidence of allergic reactions. Arch Ophthalmol 1995;113: 293-296.
16. Pfister RR, Burstem N: The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: A scanning electron microscope study. Invest Ophthalmol 1976;15:246-259.
17. Feher JM, Scuderi GL, Librando A, Messina A, Cafa F, Librando G: Effeti a lungo termine dei beta-bloccanti senza conservanti sulla superficie corneale del coniglio: uno studio ultrastrutturale. Clin Ocul 1990;4:261-265.
18. Liu GS, Trope GE, Basu PK: The toxic effects of pilocarpine gel and drops on rabbit cornea. Curr Eye Res 1989;8:637-648.